Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiziana Masini

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|September 12, 2014
Development of inhibitors of the 2C-methyl-D-erythritol 4-phosphate (MEP) pathway enzymes as potential anti-infective agentsTiziana Masini, Anna K H Hirsch
The Indian Journal of Medical Research|May 19, 2023
Optimal management of drug-resistant tuberculosis: Can India lead the way?Tiziana Masini, Jennifer Furin, Zarir Udwadia, et al.
Drug Discovery Today|July 17, 2013
Druggability of the enzymes of the non-mevalonate-pathwayTiziana Masini, Blijke S Kroezen, Anna K H Hirsch
The European Respiratory Journal|March 24, 2018
Will regulatory issues continue to be a major barrier to access to bedaquiline and delamanid?Tiziana Masini, Janika Hauser, Rutendo Kuwana, et al.
Pharmaceutics|March 26, 2022
Assessing the Appropriateness of Formulations on the WHO Model List of Essential Medicines for Children: Development of a Paediatric Quality Target Product Profile ToolJennifer Walsh, Tiziana Masini, Benedikt D Huttner, et al.
The European Respiratory Journal|July 1, 2022
Wider access to quality-assured rifapentine-based regimens is needed to accelerate tuberculosis prevention and care globallyTiziana Masini, Avinash Kanchar, Fuad Mirzayev, et al.
Research in Social & Administrative Pharmacy : RSAP|March 23, 2022
Out of the boxes, out of the silos: The need of interdisciplinary collaboration to reduce poor-quality medical products in the supply chainTiziana Masini, Cécile Macé, Lutz Heide, et al.
Bioconjugate Chemistry|December 23, 2016
Fine-tuning Nanocarriers Specifically toward Cargo: A Competitive Study on Solubilizing Related Photosensitizers for Photodynamic TherapySebastian Wieczorek, Dario Remmler, Tiziana Masini, et al.
Macromolecular Bioscience|January 6, 2015
Combinatorial screening for specific drug solubilizers with switchable release profilesSebastian Wieczorek, Sara Vigne, Tiziana Masini, et al.
Future Microbiology|July 24, 2020
Bedaquiline and delamanid for drug-resistant tuberculosis: a clinician's perspectiveLorenzo Guglielmetti, Sheila Chiesi, Johannes Eimer, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|September 12, 2014
Development of inhibitors of the 2C-methyl-D-erythritol 4-phosphate (MEP) pathway enzymes as potential anti-infective agentsTiziana Masini, Anna K H Hirsch
The Indian Journal of Medical Research|May 19, 2023
Optimal management of drug-resistant tuberculosis: Can India lead the way?Tiziana Masini, Jennifer Furin, Zarir Udwadia, et al.
Drug Discovery Today|July 17, 2013
Druggability of the enzymes of the non-mevalonate-pathwayTiziana Masini, Blijke S Kroezen, Anna K H Hirsch
The European Respiratory Journal|March 24, 2018
Will regulatory issues continue to be a major barrier to access to bedaquiline and delamanid?Tiziana Masini, Janika Hauser, Rutendo Kuwana, et al.
Pharmaceutics|March 26, 2022
Assessing the Appropriateness of Formulations on the WHO Model List of Essential Medicines for Children: Development of a Paediatric Quality Target Product Profile ToolJennifer Walsh, Tiziana Masini, Benedikt D Huttner, et al.
The European Respiratory Journal|July 1, 2022
Wider access to quality-assured rifapentine-based regimens is needed to accelerate tuberculosis prevention and care globallyTiziana Masini, Avinash Kanchar, Fuad Mirzayev, et al.
Research in Social & Administrative Pharmacy : RSAP|March 23, 2022
Out of the boxes, out of the silos: The need of interdisciplinary collaboration to reduce poor-quality medical products in the supply chainTiziana Masini, Cécile Macé, Lutz Heide, et al.
Bioconjugate Chemistry|December 23, 2016
Fine-tuning Nanocarriers Specifically toward Cargo: A Competitive Study on Solubilizing Related Photosensitizers for Photodynamic TherapySebastian Wieczorek, Dario Remmler, Tiziana Masini, et al.
Macromolecular Bioscience|January 6, 2015
Combinatorial screening for specific drug solubilizers with switchable release profilesSebastian Wieczorek, Sara Vigne, Tiziana Masini, et al.
Future Microbiology|July 24, 2020
Bedaquiline and delamanid for drug-resistant tuberculosis: a clinician's perspectiveLorenzo Guglielmetti, Sheila Chiesi, Johannes Eimer, et al.
Pageof 3